健康体检

Search documents
美年大健康产业控股股份有限公司 关于召开2025年第二次临时股东大会的提示性公告
Sou Hu Cai Jing· 2025-10-10 22:50
证券代码:002044 证券简称:美年健康 公告编号:2025-070 美年大健康产业控股股份有限公司 关于召开2025年第二次临时股东大会的提示性公告 (1)现场会议召开时间:2025年10月14日(星期二)下午14:50。 (2)网络投票时间:2025年10月14日(星期二)9:15-15:00。 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假记载、误导性陈述或重大遗 漏。 特别提示: 美年大健康产业控股股份有限公司(以下简称"公司")2025年第二次临时股东大会现场会议的召开地点 为上海市静安区灵石路697号健康智谷9号楼三楼公司会议室,敬请投资者特别留意。 根据公司于2025年9月26日召开的第九届董事会第十三次(临时)会议,定于2025年10月14日召开公司 2025年第二次临时股东大会,本次股东大会将采用股东现场记名投票与网络投票表决相结合的方式召 开,《关于召开2025年第二次临时股东大会的通知》(公告编号:2025-069)已于2025年9月27日披露 在《中国证券报》、《上海证券报》、《证券时报》、《证券日报》和巨潮资讯网 (www.cninfo.com.cn)。现就本次 ...
回应客户需求 美年健康升级十大举措如何破解体检痛点?
Bei Jing Qing Nian Bao· 2025-09-25 12:38
提到体检,很多人的心情难免有些复杂:一方面,它是我们健康意识的"启蒙者"、疾病筛查的"防火 墙";另一方面,传统体检中千篇一律的项目、流水线式的流程、漫长的等待、粗略的报告解读和"检完 不管"的模式,也常让人感到无奈。"防患于未然,治病于未病",体检的本质应是一种超前于疾病的关 怀与守护。直面客户需求和痛点,美年健康以"ALL in AI"为核心战略,借助人工智能全面升级服务流 程,推动体检行业走向智能化、个性化,并于近期正式推出2025客户服务创新升级十大举措。这一系列 举措不仅提升了体检的效率和精准度,更延伸了服务链条,真正实现"检得起、检得准、检后有人管", 深刻呼应了美年健康"以客户为中心"的服务理念。 体检过程中如何保证准确性?美年健康持续优化体检分院各工作岗位的规范化操作流程(SOP),要求 全体医技护人员必须严格按照SOP全面准确执行。在检查前提前告知客户操作流程,主动说明步骤和体 感;检查中"三查七对"确认客户信息,遵守"唱说唱检"制度,让每一步操作都透明无误。 预约不用挤,导检不迷路 AI让体检流程更顺畅 北青报记者梳理本次升级发布的十大措施发现,"以客户体验为先"贯穿始终。体检时,人多拥挤 ...
美年大健康产业控股股份有限公司第九届董事会第十二次(临时)会议决议公告
Shang Hai Zheng Quan Bao· 2025-09-19 18:32
Group 1 - The company held its 12th (temporary) meeting of the 9th Board of Directors on September 19, 2025, with all 9 directors present, complying with relevant laws and regulations [2] - The Board approved a supplementary agreement to the profit forecast compensation agreement with Yanji (Shanghai) Enterprise Management Co., Ltd., aimed at protecting the interests of the company and minority shareholders [3][4] - The voting results for the proposal were 6 in favor, 0 against, and 0 abstentions, with related directors abstaining from the vote [4] Group 2 - The 33rd (temporary) meeting of the 8th Supervisory Board was also held on September 19, 2025, with all 3 supervisors present, meeting legal requirements [8] - The Supervisory Board approved the same supplementary agreement regarding the profit forecast compensation, confirming it aligns with the actual situation of both the company and Yanji [9] - The voting results for the Supervisory Board's proposal were unanimous, with 3 votes in favor, 0 against, and 0 abstentions [9] Group 3 - The company plans to acquire various health management companies through a share issuance, including significant stakes in multiple subsidiaries, such as 84% in Hengyang Meinian Health Checkup Center Co., Ltd. and 90% in Feicheng Meinian Health Management Co., Ltd. [13][17] - The company received an inquiry letter from the Shenzhen Stock Exchange regarding the share issuance for asset acquisition on August 22, 2025, and is required to respond to the inquiries before proceeding [14][18] - The revised draft of the asset acquisition report has been updated compared to the previous version disclosed on August 12, 2025, with minor adjustments that do not affect the transaction plan [19]
美年健康拟发行股份购买多家公司股权 回复审核问询函提示交易进展
Xin Lang Cai Jing· 2025-09-19 13:37
Core Viewpoint - Meinian Health plans to acquire equity stakes in 15 companies through a share issuance, including significant stakes in Hunan Meinian Health Checkup Center (84%), Ningde Meinian Health Management (81%), and Yantai Meinian Health Checkup Management (75%) [1] Group 1 - The company announced a prompt regarding the review inquiry response for the share issuance to purchase assets and related transactions on September 20, 2025 [1] - The Shenzhen Stock Exchange previously issued an inquiry letter regarding Meinian Health's application for share issuance to purchase assets on August 22, 2025 [1] - The transaction is subject to approval from the Shenzhen Stock Exchange and registration consent from the China Securities Regulatory Commission, indicating uncertainty in the approval timeline [1]
美年健康拟发行股份收购资产,推进“参变控”战略布局
Xin Lang Cai Jing· 2025-09-19 13:37
Core Viewpoint - The company aims to enhance its health examination services and resolve industry competition through a share issuance to acquire assets, thereby advancing its "participation and control" strategy [1] Group 1: Financial Overview - As of March 31, 2025, the company's cash balance is 2.299 billion yuan, with goodwill amounting to 5.141 billion yuan, representing 26.75% of total assets. The transaction is expected to add 275 million yuan in goodwill [1] - The company has a clear purpose for its cash reserves, primarily for daily operations, debt repayment, and maintaining liquidity, making the share issuance for asset acquisition reasonable [6] Group 2: Brand Management and Control - The company manages its brands, such as "Meinian Health" and "Aoya," through a structure that includes both wholly-owned and joint-venture health examination centers, with 304 wholly-owned and 262 joint-venture centers as of June 30, 2025 [2] - The company implements a unified management service agreement for joint-venture centers to oversee brand, operations, service quality, and marketing, although violations by these centers could still harm the company's brand value [2] Group 3: Acquisition Strategy and Integration - The acquisition will enhance the company's core health examination business, improving revenue and net profit, while simplifying governance structures and increasing operational efficiency [4] - The company plans to integrate acquired entities into its regional management system, granting management certain authorities to mitigate adverse effects of the acquisition [4] Group 4: Industry Competition and Compliance - The company is actively working to resolve industry competition issues, with commitments from actual controllers and related parties to address these by November 8, 2027, through acquisitions or transfers to unrelated third parties [5] Group 5: Historical Performance and Goodwill Risk - Previous acquisitions of joint-venture health examination centers have been successfully integrated into a unified management framework, with overall positive performance and no impairment of goodwill reported [7] - The estimated additional goodwill from the current transaction is 274.6429 million yuan, with potential risks of goodwill impairment if the acquired assets' performance deteriorates [8]
国海证券晨会纪要-20250908
Guohai Securities· 2025-09-08 01:05
Group 1: Company Performance Highlights - The report indicates that Meinian Health achieved a revenue of 4.1 billion yuan in H1 2025, with a year-on-year decline of 2.28%, and a net loss of 221 million yuan, which is an increase in loss by 2.59% year-on-year [4][6] - Zhongjian Technology reported a significant revenue increase of 59.46% year-on-year, reaching 464 million yuan in H1 2025, with a net profit growth of 99.15% [8][9] - Jinfat Technology's revenue for H1 2025 was 31.6 billion yuan, reflecting a 36% year-on-year increase, while net profit rose by 54% [15][16] Group 2: Strategic Initiatives and Innovations - Meinian Health is advancing its "All in AI" strategy, integrating AI technology into health management, generating 140 million yuan in revenue from AI-related services, a 62.36% increase year-on-year [6][7] - Zhongjian Technology is benefiting from the growing demand for high-performance carbon fiber in aerospace and high-end equipment, with a focus on expanding production capacity [8][11] - Jinfat Technology is leveraging new materials and innovative products to capture emerging market opportunities, with significant growth in its modified plastics and new materials segments [15][17] Group 3: Financial Projections and Ratings - Meinian Health's revenue projections for 2025-2027 are 10.4 billion, 11.4 billion, and 12.6 billion yuan, with net profits expected to grow significantly in the coming years [7] - Zhongjian Technology's revenue forecasts for 2025-2027 are 1.06 billion, 1.27 billion, and 1.59 billion yuan, with a "buy" rating maintained due to strong growth prospects [13] - Jinfat Technology anticipates revenues of 646 billion, 737 billion, and 828 billion yuan for 2025-2027, with a "buy" rating reflecting its leadership in the modified plastics industry [19]
美年健康携手国富量子、京北方,探索医疗数字资产RWA代币化新路径,开启挖掘健康数据价值新篇章
Xin Lang Zheng Quan· 2025-09-04 03:01
Core Viewpoint - The collaboration between Meinian Health, Guofu Quantum, and Jingbeifang aims to explore the value release of digital assets in the healthcare sector, leveraging each company's strengths to innovate and upgrade the health industry [1][4]. Group 1: Collaboration and Strategic Goals - Meinian Health's subsidiary has signed a framework agreement with Guofu Quantum and Jingbeifang to explore comprehensive business opportunities in the digital asset RWA (Real World Asset) field [1]. - The partnership will focus on the tokenization of medical assets under the regulatory frameworks of mainland China and Hong Kong, aiming to reshape the value chain in the healthcare sector [1][4]. - This collaboration is expected to transform Meinian Health from a "health examination service provider" to a "medical data technology platform," enhancing its cash flow structure and expanding its business capabilities [4]. Group 2: Asset and Data Strengths - As of 2024, Meinian Health operates 576 health examination centers equipped with advanced medical devices, establishing a solid foundation of tangible assets [2]. - The company has served over 200 million people, with more than 25 million health examinations conducted in 2024, accumulating extensive multimodal health data [2][9]. - Meinian Health has developed AI applications for health management, including intelligent health managers and disease risk prediction models, which enhance its service offerings and operational efficiency [2][8]. Group 3: Research and Development Achievements - Meinian Health has led a national key research project to build a health examination big data cloud platform, gathering over 130 million health examination records, which supports the value of its data assets [6][7]. - The company has published numerous research papers based on its health examination data, contributing to significant findings in public health and disease prevention [17][18]. - Collaborations with prestigious medical institutions have resulted in breakthroughs in various health-related research projects, further validating the commercial potential of its data [16][18]. Group 4: Unique Data Advantages - Meinian Health's health examination data focuses on asymptomatic populations, providing unique insights for early disease detection and prevention [11]. - The data's medical-grade accuracy and comprehensive multimodal integration enhance its value for serious medical research compared to consumer-grade health monitoring devices [12][13]. - The company's annual health examinations create a natural cohort tracking mechanism, ensuring high compliance and data integrity for longitudinal studies [14][15].
美年健康股价跌5.17%,华泰柏瑞基金旗下1只基金重仓,持有46.06万股浮亏损失13.36万元
Xin Lang Cai Jing· 2025-09-02 03:56
Group 1 - The core viewpoint of the news is that Meinian Health has experienced a decline in stock price, with a drop of 5.17% to 5.32 CNY per share, and a total market capitalization of 20.824 billion CNY [1] - Meinian Health's main business involves health check-ups and health management, with 95.67% of its revenue coming from check-up services and 4.33% from other services [1] - The company is located in Shanghai and was established on January 22, 1991, with its listing date on May 18, 2005 [1] Group 2 - Huatai Bairui Fund has one fund heavily invested in Meinian Health, specifically the Health ETF (516790), which reduced its holdings by 20,000 shares in the second quarter, now holding 460,600 shares, accounting for 2.11% of the fund's net value [2] - The Health ETF (516790) was established on August 12, 2021, with a current scale of 112 million CNY, and has reported a year-to-date return of 16.02% [2] - The fund's performance has ranked 3019 out of 4222 in the year-to-date category and 2924 out of 3781 over the past year, with a total loss of 34.38% since inception [2]
美年健康股价跌5.15%,华泰柏瑞基金旗下1只基金重仓,持有46.06万股浮亏损失13.82万元
Xin Lang Cai Jing· 2025-08-28 06:21
Group 1 - The core point of the news is that Meinian Health experienced a decline in stock price, dropping by 5.15% to 5.52 CNY per share, with a trading volume of 705 million CNY and a turnover rate of 3.20%, resulting in a total market capitalization of 21.607 billion CNY [1] - Meinian Health primarily engages in health check-ups and health management services, with 96.53% of its revenue coming from health check-up services and 3.47% from other services [1] Group 2 - From the perspective of fund holdings, Huatai-PB Fund has one fund heavily invested in Meinian Health, specifically the Health ETF (516790), which reduced its holdings by 20,000 shares in the second quarter, now holding 460,600 shares, accounting for 2.11% of the fund's net value, ranking as the ninth largest holding [2] - The Health ETF (516790) was established on August 12, 2021, with a current size of 112 million CNY, showing a year-to-date return of 13.68% and a one-year return of 33.79%, ranking 2866 out of 4222 and 2534 out of 3776 respectively, while it has incurred a loss of 35.7% since inception [2]
预防医学提质升级,离不开社会力量参与
Xin Jing Bao· 2025-08-26 09:20
Core Perspective - The release of the "Healthy China 2030 Planning Outline" signifies a profound shift in China's health care system from a "disease-centered" model to a "people-centered" approach, emphasizing prevention and the need for a robust preventive medical system [1] Group 1: Resource Allocation and Optimization - The concentration of quality medical resources in large public hospitals has led to high operational loads, with 9.55 billion total medical visits reported in 2023, many of which are for routine checks rather than urgent care [2][3] - The growth of professional health examination institutions provides an efficient "diversion" channel, allowing public hospitals to focus on critical medical challenges while meeting preventive health needs in a more optimized environment [3] Group 2: Enhancing Public Health Awareness - The entry of social capital into the health examination market has significantly increased service accessibility and frequency, transforming annual health checks from a privilege to a standard practice for the majority [4] - Market competition has driven profound changes in service models, with institutions focusing on improving service experiences and educating the public on health management tailored to different age groups [4] Group 3: Innovation in Service Models - The innovations in service models and management mechanisms by private institutions contribute qualitatively to the healthcare system, creating a "catalytic" effect that enhances overall service quality [5][6] - These institutions are adopting digital health accounts and integrating AI technologies into various health services, improving diagnostic efficiency and pushing for technological advancements in the industry [6] Group 4: Collaborative Ecosystem - The collaboration between public and private healthcare entities is essential for deepening the preventive medical system, ultimately aiming for comprehensive health and well-being for all citizens [7]